Core Insights - The J.M. Smucker Company is set to announce its quarterly earnings on November 25, 2025, with Wall Street expecting an EPS of $2.11 and revenue of approximately $2.32 billion [1][4] Financial Performance - A projected EPS of $2.14 indicates a 22.5% decrease year-over-year, while revenue is expected to grow by 2.1% to $2.32 billion, driven by strong coffee sales [2][3] - The consensus estimate for EPS is $2.11, reflecting a 23.6% decline from the previous year, with an average earnings surprise of 5.1% over the last four quarters [4] Challenges and Market Conditions - The company faces challenges in its snacks and pet foods divisions, alongside increased costs from higher coffee tariffs, contributing to the anticipated earnings decline [3] - Key financial ratios include a price-to-sales ratio of 1.29, an enterprise value to sales ratio of 2.21, a debt-to-equity ratio of 1.36, and a current ratio of 0.81, indicating potential liquidity issues [5]

As filed with the Securities and Exchange Commission on November 4, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SRx HEALTH SOLUTIONS, INC. (Exact name of registrant as specified in its charter) (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION) DELAWARE 5961 83-4284557 (PRIMARY STANDARD INDUSTRIAL CLASSIFICATION CODE NUMBER) (I.R.S. EMPLOYER IDENTIFICATION NUMBER) 12400 Race Tr ...